Last reviewed · How we verify
dexmedetomidine hydrochloride for injection — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
dexmedetomidine hydrochloride for injection (dexmedetomidine hydrochloride for injection) — Peking University First Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| dexmedetomidine hydrochloride for injection TARGET | dexmedetomidine hydrochloride for injection | Peking University First Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- dexmedetomidine hydrochloride for injection CI watch — RSS
- dexmedetomidine hydrochloride for injection CI watch — Atom
- dexmedetomidine hydrochloride for injection CI watch — JSON
- dexmedetomidine hydrochloride for injection alone — RSS
Cite this brief
Drug Landscape (2026). dexmedetomidine hydrochloride for injection — Competitive Intelligence Brief. https://druglandscape.com/ci/dexmedetomidine-hydrochloride-for-injection. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab